| Price | 5.10 |
| Price Change Today | -$0.04 (-0.78%) |
| P&P rating | ![]() |
| Zacks Rank | 4 - SELL |
| Open Price | $5.18 |
| Previous Close | $5.14 |
| Daily Range | $5.07 - $5.20 |
| 52-Week Range | $3.30 - $6.88 |
| Volume | 123,115 |
| Sciclone Pharmaceuticals, Inc. develops and commercializes novel medicines for treating a broad range of the world's most serious diseases. They have focused their current product development and commercial activities on the following diseases: hepatitis C, hepatocellular carcinoma, malignant melanoma, hepatitis B, HIV, drug-resistant tuberculosis, cystic fibrosis and others. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment